PolyPeptide Group AG (SWX:PPGN)
Switzerland · Delayed Price · Currency is CHF 46.05
+0.35 (0.77%)
Jul 14, 2026, 11:19 AM CET
PolyPeptide Group AG Market Cap
PolyPeptide Group AG has a market cap or net worth of 1.51 billion as of July 14, 2026. Its market cap has increased by 127.43% in one year.
Market Cap
1.51B
Enterprise Value
1.57B
Revenue
362.47M
Ranking
n/a
PE Ratio
n/a
Stock Price
46.05
Market Cap Chart
Since April 29, 2021, PolyPeptide Group AG's market cap has decreased from 2.59B to 1.51B, a decrease of -41.77%. That is a compound annual growth rate of -9.86%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 14, 2026 | 1.51B | 75.18% |
| Dec 30, 2025 | 861.08M | -8.08% |
| Dec 30, 2024 | 936.73M | 62.30% |
| Dec 29, 2023 | 577.18M | -30.79% |
| Dec 30, 2022 | 833.98M | -81.57% |
| Dec 30, 2021 | 4.53B | 74.70% |
| Apr 29, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Roche Holding AG | 263.70B |
| Novartis AG | 228.05B |
| Lonza Group AG | 41.11B |
| Galderma Group AG | 40.03B |
| Tecan Group AG | 2.29B |
| Idorsia | 1.55B |
| SKAN Group AG | 1.34B |
| Medartis Holding AG | 1.13B |